SYNDAX PHARMACEUTICALS, INC.

SNDX US87164F1057

🆔
Registration No.
4043376
💰
Capitalization
Small-cap

Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company's product candidates are entinostat which has direct effects on both cancer cells and immune regulatory cells, SNDX-6352 and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the body's immune response on tumors that have shown sensitivity to immunotherapy. Business activity of the group is primarily functioned through the region of United States.

🔗
Website
Annual Insiders Turnover, USD 2

1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);

Insider Activity
📊
Transactions
16
🙍
Insiders
7
Person Price Shares Total Published Completed
Metzger Michael A
CEO 		16.41
USD 		157,307
Sold 		2,582,021
USD 		08/09/2025 08/09/2025
Podlesak Dennis
 15.84
USD 		19,200
Sold 		304,170
USD 		14/08/2025 18/08/2025
Podlesak Dennis
 15.54
USD 		19,200
Sold 		298,408
USD 		14/08/2025 15/08/2025
Podlesak Dennis
 14.19
USD 		19,200
Sold 		272,521
USD 		14/08/2025 14/08/2025
Goldan Keith A.
CFO 		9.29
USD 		1,296
Sold 		12,033
USD 		16/07/2025 16/07/2025
Metzger Michael A
CEO 		9.29
USD 		7,534
Sold 		69,953
USD 		16/07/2025 16/07/2025
Huber Martin H. Jr.
 8.99
USD 		5,000
Bought 		44,950
USD 		19/05/2025 19/05/2025
Huber Martin H. Jr.
 8.99
USD 		5,000
Bought 		44,950
USD 		19/05/2025 19/05/2025
Katkin Keith
 9.11
USD 		10,000
Bought 		91,120
USD 		19/05/2025 19/05/2025
Katkin Keith
 9.11
USD 		10,000
Bought 		91,120
USD 		19/05/2025 19/05/2025

Integrated EOD Stock Data and Insider Transactions Chart

Sign in or subscribe to include SYNDAX PHARMACEUTICALS, INC. to your watchlist and receive automatic alerts for upcoming transactions.

The visibility of insider buy and sell transactions on this chart should not be the sole factor in your decision to buy or sell a particular stock. Always consider the following dynamic reports for a broader understanding of stock market activities:

 

Last 52W Low 52W High All-Time Low All-Time High β
Company Insiders
Person / Entity Transactions Turnover, USD Average, USD First Last
Metzger Michael A 4 2,975,555.68 743,888.92 10/02/2025 08/09/2025
Podlesak Dennis 3 875,099.52 291,699.84 14/08/2025 18/08/2025
Katkin Keith 2 182,240.00 91,120.00 19/05/2025 19/05/2025
Botwood Nicholas A.j. 1 105,826.17 105,826.17 16/05/2025 16/05/2025
Goldan Keith A. 3 95,629.22 31,876.41 14/06/2024 16/07/2025
Huber Martin H. Jr. 2 89,900.00 44,950.00 19/05/2025 19/05/2025
Gallagher Neil 1 71,597.47 71,597.47 10/02/2025 10/02/2025

Insiders marked in yellow represent long-term insiders. These are individuals who have engaged in transactions for over 3 years and have conducted at least 10 transactions or reached a cumulative turnover of $1M USD. When examining transaction clusters, we prioritize those conducted by long-term insiders for analysis.

Stock Advanced Metrics
Delta Correlation subscribe 🔒
Upper Bound of Standardized Transaction Amount (ubsta), USD 4 subscribe 🔒

4 represents the maximum expected transaction amount for a company's insiders, calculated based on historical data. It provides insight into the typical range of insider transaction amounts and helps in identifying unusually large transactions.

5 a proprietary metric reflecting the consistency of insider trading behavior within a company. A higher discipline index suggests more regular and predictable insider transactions.